The case itself had something to do with patents that are being held by Myriad Genetics, a company in Utah, concerning genes which correlate with an increased risk of hereditary breast and ovarian cancer. The main question for the justices in the case is this, in Association for Molecular Pathology v. Myriad Genetics? What do you think of the entire situation, and do you agree with the Supreme Court’s ruling?
It goes without saying that the court’s ruling will definitely shape the course of scientific research as well as medical testing, and who knows, it might very well change the mindset of businesses so that they will plow more money into the extremely expensive work to isolate and understand genetic material better.